Flagler Health Raises $50M Series B
Flagler Health raised a $50 million Series B round for its AI-native musculoskeletal care platform on August 11. Fierce Healthcare reports that Bessemer Venture Partners led the financing, joined by SignalFire, Alumni Ventures, Streamlined, 186 Ventures, Proof VC, Tribeca Ventures and Offscript. The company reported $63 million in total funding and described the capital as supporting expansion of its MSK platform.
Flagler Health raised a $50 million Series B to expand its AI-native platform for musculoskeletal care. Bessemer Venture Partners led the round, according to Fierce Healthcare, with participation from SignalFire, Alumni Ventures, Streamlined, 186 Ventures, Proof VC, Tribeca Ventures and Offscript.
The financing brings Flagler's total funding to $63 million, Fierce Healthcare reported. Axios Pro separately reported that Flagler is a musculoskeletal-focused practice management software company and that CEO Albert Katz disclosed the Series B to the publication.
Platform scope and reported performance
Flagler's platform addresses workflows across the MSK patient lifecycle, including triage, care management, billing and patient communications, according to Fierce Healthcare. The company told Fierce that the software integrates with existing electronic medical record systems and is trained on one of the largest MSK patient datasets.
Fierce reported that Flagler serves thousands of MSK providers in more than 36 states. Company-reported metrics cited by the publication include an average of $164,000 in additional annual revenue per provider and patient-reported improvement in pain, mood, sleep or mobility for 87% of patients. Those figures are company claims rather than independently reported clinical or financial outcomes.
Christopher Netzel, an interventional pain physician at Coastal Health, described the product in a company statement cited by Fierce as a remote patient-outcome tracking system with no new logins, training or extra clicks for clinicians.
MSK operations are a large target market
Fierce Healthcare cited Flagler's estimate that musculoskeletal conditions affect more than half of US adults and account for more than $400 billion in annual healthcare spending. The company also told Fierce that physicians spend nearly 75% of their time on non-revenue-generating work, including documentation and administrative tasks.
Bessemer partner Steve Kraus said in a statement that the investment firm was drawn to the founders' combination of healthcare operations experience, clinical authority and AI expertise. He described MSK as one of healthcare's largest underserved markets and characterized Flagler as a full-stack MSK platform.
For healthcare AI teams, the relevant technical distinction is the integration point. Systems connected to EMRs and operational workflows face different evaluation criteria than standalone clinical copilots: implementation effort, data interoperability, workflow adoption, outcome measurement and billing operations all become part of deployment validation. Across comparable healthcare automation deployments, vendor-reported ROI metrics require site-level review against baseline utilization, reimbursement rules and independently measured patient outcomes.
The round is another sizable financing for software targeting specialty-care operations, where data fragmentation and administrative workload can limit the usefulness of point AI tools. Public reporting does not provide details on Flagler's model architecture, dataset governance, validation methodology or regulatory posture.
Key Points
- 1Flagler raised $50 million from Bessemer-led investors, providing new capital for an AI platform focused on musculoskeletal practice operations.
- 2The platform spans triage, care management, billing and communications, making EMR integration and workflow adoption central deployment considerations.
- 3Company-reported revenue and patient-outcome metrics are notable, but healthcare buyers typically require independent, site-specific validation before procurement.
Scoring Rationale
A $50 million Series B is a notable healthcare AI financing event, particularly because the product targets integrated specialty-care operations rather than a narrow point workflow. Its practitioner impact depends on evidence around EMR integration, clinical validation, data governance and reproducible outcomes, which public reporting has not detailed.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems

